111 related articles for article (PubMed ID: 31364042)
1. Classical Immunoproteomics: Serological Proteome Analysis (SERPA) for Antigen Identification.
Fulton KM; Ananchenko A; Wolfraim L; Martin S; Twine SM
Methods Mol Biol; 2019; 2024():59-78. PubMed ID: 31364042
[TBL] [Abstract][Full Text] [Related]
2. Methods and applications of serological proteome analysis.
Fulton KM; Martin SS; Wolfraim L; Twine SM
Methods Mol Biol; 2013; 1061():97-112. PubMed ID: 23963932
[TBL] [Abstract][Full Text] [Related]
3. Proteomics approaches towards antigen discovery and vaccine development.
Klade CS
Curr Opin Mol Ther; 2002 Jun; 4(3):216-23. PubMed ID: 12139306
[TBL] [Abstract][Full Text] [Related]
4. Serological Proteome Analysis for the Characterization of Secreted Fungal Protein Antigens.
Macheleidt J; Kniemeyer O
Methods Mol Biol; 2021; 2260():15-26. PubMed ID: 33405028
[TBL] [Abstract][Full Text] [Related]
5. Immunoproteomics: the key to discovery of new vaccine antigens against bacterial respiratory infections.
Dennehy R; McClean S
Curr Protein Pept Sci; 2012 Dec; 13(8):807-15. PubMed ID: 23305366
[TBL] [Abstract][Full Text] [Related]
6. Intranasal administration of a two-dose adjuvanted multi-antigen TMV-subunit conjugate vaccine fully protects mice against Francisella tularensis LVS challenge.
McCormick AA; Shakeel A; Yi C; Kaur H; Mansour AM; Bakshi CS
PLoS One; 2018; 13(4):e0194614. PubMed ID: 29684046
[TBL] [Abstract][Full Text] [Related]
7. Passive protection of mice against lethal Francisella tularensis (live tularemia vaccine strain) infection by the sera of human recipients of the live tularemia vaccine.
Drabick JJ; Narayanan RB; Williams JC; Leduc JW; Nacy CA
Am J Med Sci; 1994 Aug; 308(2):83-7. PubMed ID: 8042659
[TBL] [Abstract][Full Text] [Related]
8. Proteomic analysis of anti-Francisella tularensis LVS antibody response in murine model of tularemia.
Havlasová J; Hernychová L; Brychta M; Hubálek M; Lenco J; Larsson P; Lundqvist M; Forsman M; Krocová Z; Stulík J; Macela A
Proteomics; 2005 May; 5(8):2090-103. PubMed ID: 15892173
[TBL] [Abstract][Full Text] [Related]
9. The francisella tularensis proteome and its recognition by antibodies.
Kilmury SL; Twine SM
Front Microbiol; 2010; 1():143. PubMed ID: 21687770
[TBL] [Abstract][Full Text] [Related]
10. Secretome, surfome and immunome: emerging approaches for the discovery of new vaccine candidates against bacterial infections.
Dwivedi P; Alam SI; Tomar RS
World J Microbiol Biotechnol; 2016 Sep; 32(9):155. PubMed ID: 27465855
[TBL] [Abstract][Full Text] [Related]
11. Immunoproteomics Methods and Techniques.
Fulton KM; Baltat I; Twine SM
Methods Mol Biol; 2019; 2024():25-58. PubMed ID: 31364041
[TBL] [Abstract][Full Text] [Related]
12. [Tularemia vaccine strain is a potential vector].
Pavlov VM; Mokrievich AN; Noskov AN; Urakov NN
Vestn Ross Akad Med Nauk; 1997; (6):30-2. PubMed ID: 9289276
[TBL] [Abstract][Full Text] [Related]
13. Pre-absorbed immunoproteomics: a novel method for the detection of bacterial surface proteins.
Liu G; Zhang W; Lu C
Methods Mol Biol; 2013; 1061():113-21. PubMed ID: 23963933
[TBL] [Abstract][Full Text] [Related]
14. Immunotherapy of tularemia: characterization of a monoclonal antibody reactive with Francisella tularensis.
Narayanan RB; Drabick JJ; Williams JC; Fortier AH; Meltzer MS; Sadoff JC; Bolt CR; Nacy CA
J Leukoc Biol; 1993 Jan; 53(1):112-6. PubMed ID: 8426087
[TBL] [Abstract][Full Text] [Related]
15. Identification of vaccine candidate antigens of Staphylococcus pseudintermedius by whole proteome characterization and serological proteomic analyses.
Couto N; Martins J; Lourenço AM; Pomba C; Varela Coelho A
J Proteomics; 2016 Feb; 133():113-124. PubMed ID: 26721443
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of Francisella tularensis ΔpdpC as a candidate live attenuated vaccine against respiratory challenge by a virulent SCHU P9 strain of Francisella tularensis in a C57BL/6J mouse model.
Tian D; Uda A; Park ES; Hotta A; Fujita O; Yamada A; Hirayama K; Hotta K; Koyama Y; Azaki M; Morikawa S
Microbiol Immunol; 2018 Jan; 62(1):24-33. PubMed ID: 29171073
[TBL] [Abstract][Full Text] [Related]
17. Immunoproteomics of Aspergillus for the development of biomarkers and immunotherapies.
Kniemeyer O; Ebel F; Krüger T; Bacher P; Scheffold A; Luo T; Strassburger M; Brakhage AA
Proteomics Clin Appl; 2016 Oct; 10(9-10):910-921. PubMed ID: 27312145
[TBL] [Abstract][Full Text] [Related]
18. Protection of vaccinated mice against pneumonic tularemia is associated with an early memory sentinel-response in the lung.
Bar-On L; Cohen H; Elia U; Rotem S; Bercovich-Kinori A; Bar-Haim E; Chitlaru T; Cohen O
Vaccine; 2017 Dec; 35(50):7001-7009. PubMed ID: 29102170
[TBL] [Abstract][Full Text] [Related]
19. Immunoproteomics technologies in the discovery of autoantigens in autoimmune diseases.
Ganesan V; Ascherman DP; Minden JS
Biomol Concepts; 2016 May; 7(2):133-43. PubMed ID: 27115324
[TBL] [Abstract][Full Text] [Related]
20. Tularemia vaccines.
Putzova D; Senitkova I; Stulik J
Folia Microbiol (Praha); 2016 Nov; 61(6):495-504. PubMed ID: 27194547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
